Skip to main content
. 2018 Mar 18;2018:3513206. doi: 10.1155/2018/3513206

Table 2.

Comparison of laboratory data between A-AIH and C-AIH patients.

Acute
n = 32 (40.0%)
Chronic
n = 48 (60.0%)
P
HGB (g/L) 116 ± 21 118 ± 26 0.687
PLT (109/L) 112 (76, 169) 121 (76, 160) 0.757
WBC (109/L) 5.24 (3.51, 6.43) 4.50 (3.72, 5.69) 0.556
TB (µmol/L) 93 (48.1, 198.9) 17.8 (13.5, 24.3) <0.001a
DB (µmol/L) 83.2 (30.3, 157.4) 6.7 (4.7, 11.3) <0.001a
ALT (IU/L) 330 (149, 452) 42 (22, 97) <0.001a  
AST (IU/L) 394 (208, 557) 45 (34, 87) <0.001a
AST/ALT 1.21 (0.98, 1.74) 1.13 (0.94, 1.65) 0.694
ALB (g/L) 34.3 ± 5.4 40.1 ± 5.8 <0.001a
GLB (g/L) 42.7 (35.8, 47) 35.8 (31.4, 41.3) 0.001a
ALP (IU/L) 144 (125, 173) 98 (80, 146) <0.001a
GGT (IU/L) 128 (63, 225) 58 (27, 110) 0.003a
PT (s) 14.7 (13.2, 16.3) 12.8 (11.9, 13.4) <0.001a
INR 1.27 (1.12, 1.39) 1.09 (1.01, 1.13) <0.001a
IgG (g/L) 30.8 (21.5, 33.2) 19.3 (16, 24.7) <0.001a

ANA
 <1 : 100 4 (12.5%) 21 (44.7%) 0.003a
 ≥1 : 100 28 (87.5%) 26 (55.3%)

AMA
 − 27 (84.4%) 43 (97.7%) 0.322
 + 5 (15.6%) 1 (2.3%)

LKM
 − 32 (100%) 43 (97.7%) 1.000
 + 0 1 (2.3%)

LC-1
 − 32 (100%) 43 (97.7%) 1.000
 + 0 0
 ± 0 1 (2.3%)

SLA
 − 31 (96.9%) 41 (93.2%) 1.000
 + 1 (3.1%) 3 (6.8%)

ANCA
 − 14 (77.8%) 19 (79.2%) 0.178
 + 2 (11.1%) 0
 ± 2 (11.1%) 5 (20.8%)

Coombs
 − 6 (42.9%) 14 (66.7%) 0.091
 + 8 (57.1%) 6 (28.5%)
 ± 0 1 (4.8%)

a P < 0.05. AIH: autoimmune hepatitis; IAIHG: international autoimmune hepatitis group; HGB: haemoglobin; PLT: platelet; WBC: white blood cell; TB: total bilirubin; DB: direct bilirubin; ALT: alanine aminotransferase; AST: aspartate transaminase; ALB: albumin; GLB: globulin; ALP: alkaline phosphatase; GGT: gamma-glutamyl transferase; PT: prothrombin time; INR: international normalized ratio; IgG: immunoglobulin G; ANA: anti-nuclear antibody; AMA: anti-mitochondrial antibody; LKM: liver kidney microsomal; LC: liver cytosol; SLA: soluble liver antigen; ANCA: anti-neutrophil cytoplasmic antibody; Coombs: Coombs test.